GOLGA2P10

Across TCGA pan-cancer cohorts, GOLGA2P10 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of GOLGA2P10’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where GOLGA2P10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types GOLGA2P10 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.

LIHC, KIRP, and THCA are the cancer types where GOLGA2P10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in GOLGA2P10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.877	<.001	9	view →
KIRP	All	All	+0.563	.006	7	view →
THCA	All	All	−0.428	<.001	5	view →
CHOL	Female	All	+3.066	<.001	3	view →
KIRC	All	All	+0.243	.010	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

GOLGA2P10–LIHC

Open the LIHC breakdown →